Investors love the new forecast and report for Idera Pharmaceuticals Inc(IDRA)

Idera Pharmaceuticals Inc(IDRA) is a stock of interest due to the large impact the company has on the market. Here at Wall Street Facts we only cover the best stocks so make sure you check out our other articles. Today we will be diving deep into all of the essential information you need to know about IDRA. We will be studying the movement so you can make the best decision as an investor.

First, here is information about the company and how it functions: Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.

The stock has moved upwards today by 3.08%. The high for today is 1.39 and today’s low is 1.31. This information is critical in deciding whether this investment is risky or not. We can see the stock is trending upwards, which means the volume of people buying this stock is greater than people selling it. Next we will be going over the forecast.

As an investor, you can get an idea where the stock is trending by the forecast. In this case the high forecast for Idera Pharmaceuticals Inc is $9.00 and the low forecast is $4.00. We can get a look into the future by looking at past trends. Looking at Idera Pharmaceuticals Inc’s 5 year movement it seems it has fallen 91%. Overall, Idera Pharmaceuticals Inc is in great shape going forward. They have a strong market cap of $56.62M and a very bright future ahead fo them.

Leave a Reply

%d bloggers like this: